Ascentage Pharma Group International (AAPG) Current Assets (2023 - 2025)
Historic Current Assets for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $266.4 million.
- Ascentage Pharma Group International's Current Assets changed N/A to $266.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $266.4 million, marking a year-over-year change of. This contributed to the annual value of $202.0 million for FY2024, which is 618.0% up from last year.
- Ascentage Pharma Group International's Current Assets amounted to $266.4 million in Q2 2025.
- Over the past 5 years, Ascentage Pharma Group International's Current Assets peaked at $266.4 million during Q2 2025, and registered a low of $186.7 million during Q4 2023.
- For the 3-year period, Ascentage Pharma Group International's Current Assets averaged around $219.5 million, with its median value being $205.2 million (2024).
- Within the past 5 years, the most significant YoY rise in Ascentage Pharma Group International's Current Assets was 992.94% (2024), while the steepest drop was 992.94% (2024).
- Over the past 3 years, Ascentage Pharma Group International's Current Assets (Quarter) stood at $186.7 million in 2023, then increased by 9.93% to $205.2 million in 2024, then rose by 29.83% to $266.4 million in 2025.
- Its Current Assets stands at $266.4 million for Q2 2025, versus $205.2 million for Q4 2024 and $186.7 million for Q4 2023.